Last reviewed · How we verify

NCT07316322

Central Sensitization in Painful and Painless Diabetic Peripheral Neuropathy

Not yet recruiting Last updated 5 January 2026
What this trial tests

trial in Diabetes Mellitus (DM) in 128 participants. Not yet recruiting.

Timeline
15 December 2025
Primary endpoint
15 September 2026
15 September 2026

Quick facts

Lead sponsorInonu University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment128
Start date15 December 2025
Primary completion15 September 2026
Estimated completion15 September 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 80, any sex, with Diabetes Mellitus (DM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is structured as a cross-sectional observational study. The primary objective is to compare central sensitization across painful and painless phenotypes of diabetic peripheral neuropathy. The study will be conducted among individuals diagnosed with type 2 diabetes mellitus at the Department of Geriatrics, İnönü University Turgut Özal Medical Center. All assessments will be administered in accordance with a rigorously standardized protocol. Eligible participants will include individuals aged 18 to 80 years who have had a confirmed diagnosis of type 2 diabetes mellitus for at least one year, are capable of comprehending and following verbal instructions in Turkish required for the study procedures, and provide written informed consent. All statistical analyses will be performed using IBM SPSS Statistics (v.29, Armonk, NY, USA) and JASP (v.0.18, Amsterdam, Netherlands).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus (DM)

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07316322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing